Mastocytoses
DOI:
https://doi.org/10.66344/jpad.14.1.2004.774Abstract
Mastocytoses are an important group of dermatoses characterized by histologicalinfiltrates predominantly rich in mast cells. The present review focuses on the salientclinical, diagnostic and therapeutic features of different ent ities included in this group.References
Clark DP, Buescher L, Havey A. Familial urticaria pigmentosa. Arch Intern Med 1990; 150: 1742-4.
Hass N, Hamann K, Grabbe J. Phenotypic characterization of skin lesions of urticaria pigmentosa and mastocytomas. Arch Dermatol Res 1995; 287: 247-8.
Longley J, Duffy TP, Kohn S. The mast cell and mast cell disease. J Am Acad Dermatol 1995; 32: 545-61.
Niordson AM. Urticaria pigmentosa: age of onset and prognosis. Acta Derm Venereol (Stockh) 1962; 42: 433-9.
Greaves MW, Sondergaard J. Urticaria pigmentosa and factitious urticaria: direct evidence for release of histamine and other smooth muscle-contracting agents in dermographic skin. Arch Dermatol 1970; 101: 418-25.
Sanchez R, Oblender M, Raimer S. Leukemia cutis: Darier’s sign in neonate with acute lymphoblastic leukemia. J Am Acad Dermatol 1996; 34: 375-8.
Nagayo K, Sakai M, Mizuno N. Juvenile xanthogranuloma with Darier’s sign. J Dermatol 1983; 10: 283-5.
Caplan RM. The natural course of urticaria pigmentosa. Analysis and follow up of 112 cases. Arch Dermatol 1963; 87: 146-57.
Aubin F, Gutknecht J, Faivre B. Unusual ecchymotic presentation of systemic mastocytosis. Eur J Dermatol 1995; 5: 237-9.
Gebauer KA, Navaratnam TE, Holgate C. Pruritic pigmented papules posing permanent problems. Urticaria pigmentosa (UP) with secondary anetoderma. Arch Dermatol 1992; 128: 105-10.
Bac DJ, Van Marwijk Kooy M. Mastocytosis and Sjogren’s syndrome. Ann Rheum Dis 1992; 128: 105-10.
Christopher SE, Honigsman MH, Wolff K. PUVA treatment of urticaria pigmentosa. Br J Dermatol 1978; 98: 701-2.
Vella Briffa D, Eady RAJ, James MP. Photochemotherapy (PUVA) in the treatment of urticaria pigmentosa. Br J Dermatol 1983; 109: 67-75.
Barton J, Lavker RM, Schechter NM, Lazarus GS. Treatment of urticaria pigmentosa with corticosteroids. Arch Dermatol 1985; 121: 1516-23.
Kolde G, Sunderkotter C, Luger TA. Treatment of urticaria pigmentosa using interferon alpha. Br J Dermatol 1995; 133: 91-4.
Guzzo C, Lavker R, Roberts LJ. Urticaria pigmentosa: system evaluation and successful treatment with topical steroids. Arch Dermatol 1994; 127: 191-6.
Moynahan EJ. Urticaria pigmentosa (telangiectasia macularis eruptiva perstans). Proc R Soc Med 1949; 42: 346-7.
Warin RP, Hughes RCW. Diffuse cutaneous mastocytosis. Br J Dermatol 1963; 65: 296-7.
Griffiths WAD, Daneshbod K. Pseudoxanthomatous mastocytosis. Br J Dermatol 1975; 93: 91-5.
Johnson EC, Helwig EB. Solitary mastocytosis (urticaria pigmentosa). Arch Dermatol 1961; 84: 806-15.
Birt AR, Nickerson M. Generalized flushing of the skin with urticaria pigmentosa. Arch Dermatol 1959; 80: 311-17.
Ferguson J, Thompson RPH, Greaves MW. Intestinal mucosal mast cells: enumeration in urticaria pigmentosa and systemic mastocytosis. Br J Dermatol 1988; 119: 573-8.
Bank S, Marks JN. Malabsorption in systemic mast cell disease. Gastroenterology 1963; 45: 535-49.
Kettelhu BV, Metcalfe DD. Pediatric Mastocytosis. J Invest Dermatol 1991; 96: 15S-18S.
Travis WD, Li C-Y, Hoagland HC. Mast cell leukemia: report of a case and review of the literature. Mayo Clin Proc 1986; 61: 957-66.
Kors JW, Van Doormaal JJ, Breukelman H. Long term follow up of indolent mastocytosis in adults. J Intern Med 1996; 239: 157-64.
Downloads
Published
How to Cite
Issue
Section
License
Submission declaration
Authors retain the copyright to their work and grant the 'Journal of Pakistan Association of Dermatologists (JPAD)' the right of first publication under a Creative Commons Attribution 4.0 International (CC BY 4.0) license. This license allows others to share, adapt, and reuse the work for any purpose, including commercial use, as long as appropriate credit is given to the original authors and the journal.
By submitting a manuscript, authors confirm that the work has not been published previously (except as an abstract, lecture, or academic thesis), is not under review elsewhere, and has been approved by all authors and relevant authorities. Once accepted, the article will be openly accessible under the CC BY 4.0 license, ensuring wide dissemination and reuse with proper attribution.
